Mirador Capital Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$756K Hold
5,882
0.09% 122
2026
Q1
$708K Sell
5,882
-343
-6% -$39.6K 0.1% 111
2025
Q4
$655K Sell
6,225
-273
-4% -$25.6K 0.09% 126
2025
Q3
$545K Buy
6,498
+67
+1% +$5.52K 0.08% 139
2025
Q2
$509K Hold
6,431
0.08% 138
2025
Q1
$577K Buy
6,431
+277
+5% +$25.9K 0.1% 123
2024
Q4
$612K Buy
6,154
+243
+4% +$25.1K 0.11% 117
2024
Q3
$671K Buy
5,911
+8
+0.1% +$950 0.12% 112
2024
Q2
$731K Sell
5,903
-634
-10% -$81.7K 0.14% 98
2024
Q1
$863K Buy
6,537
+475
+8% +$58.5K 0.16% 97
2023
Q4
$661K Sell
6,062
-191
-3% -$19.8K 0.14% 100
2023
Q3
$644K Sell
6,253
-284
-4% -$30.6K 0.15% 103
2023
Q2
$754K Sell
6,537
-102
-2% -$11.6K 0.18% 95
2023
Q1
$706K Sell
6,639
-60
-0.9% -$6.48K 0.17% 89
2022
Q4
$743K Buy
6,699
+1
+0% +$102 0.18% 87
2022
Q3
$577K Sell
6,698
-504
-7% -$45K 0.14% 99
2022
Q2
$657K Buy
7,202
+1
+0% +$89 0.16% 98
2022
Q1
$591K Sell
7,201
-100
-1% -$7.88K 0.12% 127
2021
Q4
$560K Hold
7,301
0.12% 130
2021
Q3
$548K Buy
7,301
+85
+1% +$6.46K 0.12% 126
2021
Q2
$561K Sell
7,216
-529
-7% -$39.3K 0.13% 125
2021
Q1
$570K Buy
7,745
+534
+7% +$39.4K 0.15% 112
2020
Q4
$563K Sell
7,211
-16,050
-69% -$1.23M 0.15% 111
2020
Q3
$1.84M Sell
23,261
-7,526
-24% -$589K 0.57% 52
2020
Q2
$2.27M Buy
30,787
+469
+2% +$35.3K 0.85% 38
2020
Q1
$2.23M Buy
30,318
+2,549
+9% +$200K 0.93% 35
2019
Q4
$2.41M Sell
27,769
-322
-1% -$26.4K 0.97% 31
2019
Q3
$2.26M Buy
28,091
+44
+0.2% +$3.53K 1.01% 31
2019
Q2
$2.24M Buy
28,047
+20,232
+259% +$1.55M 1.11% 30
2019
Q1
$620K Buy
7,815
+2,530
+48% +$189K 0.34% 72
2018
Q4
$385K Sell
5,285
-439
-8% -$31K 0.24% 82
2018
Q3
$387K Sell
5,724
-3
-0.1% -$191 0.19% 102
2018
Q2
$332K Buy
5,727
+494
+9% +$27.9K 0.18% 104
2018
Q1
$294K Sell
5,233
-48
-0.9% -$2.59K 0.21% 93
2017
Q4
$284K Sell
5,281
-24,241
-82% -$1.34M 0.16% 110
2017
Q3
$1.82M Buy
29,522
+339
+1% +$20.6K 1.07% 33
2017
Q2
$1.76M Buy
29,183
+514
+2% +$31.3K 1.08% 26
2017
Q1
$1.74M Sell
28,669
-195
-0.7% -$11.8K 1.27% 24
2016
Q4
$1.62M Sell
28,864
-1,694
-6% -$99.1K 1.3% 25
2016
Q3
$1.82M Sell
30,558
-300
-1% -$17.5K 1.6% 18
2016
Q2
$1.7M Sell
30,858
-1,745
-5% -$92.9K 1.7% 19
2016
Q1
$1.65M Buy
+32,603
New +$1.6M 1.82% 15

Other funds holding MRK

Mirador Capital Partners's MRK Position: Q2 2026 in Review

Mirador Capital Partners held its Merck (MRK) position steady in Q2 2026 at 5,882 shares worth $756K. The position accounts for 0.09% of the portfolio, ranked #122.

Mirador Capital Partners first reported a position in MRK in Q1 2016 and has held it in 42 quarters since. The position peaked at $2.41M in Q4 2019. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Mirador Capital Partners held 5,882 shares of Merck worth $756K as of Q2 2026.
  • Mirador Capital Partners left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.09% of Mirador Capital Partners's portfolio in Q2 2026, its #122 holding.
  • Mirador Capital Partners first reported a position in Merck in Q1 2016 and has held it in 42 quarters since.
  • Mirador Capital Partners's Merck position peaked at $2.41M in Q4 2019.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Mirador Capital Partners's 13F filing for Q2 2026, filed 7 Jul 2026.